$RVTY is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $RVTY, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
$RVTY is currently facing 1 active congressional signal tracked by HillSignal. With 1 bullish, and 0 bearish signal, the average legislative impact score is 6.0/10. Key sectors affected include Healthcare. Recent major catalysts include ASAP Act. Below is the complete tracker of government activity affecting $RVTY’s market performance.
The ASAP Act mandates Medicare coverage for blood-based dementia screening tests starting January 1, 2028. This creates a new, substantial market for diagnostic companies developing and commercializing FDA-approved blood tests for Alzheimer's and related dementias. Companies with existing or developing blood-based diagnostic platforms gain significantly.
Impact: 6/10(Early stage (action not classified))HR6130Congressional Bill